利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

11 条记录 (耗时 0.042 秒)

    Ion implanter
    5.
    发明授权
    Ion implanter 失效
    离子注入机

    公开(公告)号：US5218209A

    公开(公告)日：1993-06-08

    申请号：US826141

    申请日：1992-01-27

    申请人： Kunihiko Takeyama

    发明人： Kunihiko Takeyama

    IPC分类号： H01J37/317 ,  H01L21/265 ,  H01L21/683 ,  H01L21/687

    CPC分类号： H01L21/68764 ,  H01J37/3171 ,  H01L21/68771 ,  H01J2237/2007

    摘要： An ion implanter for implanting ions into a batch of semiconductor wafers comprises a wafer holding disk of the centrifugal holding type, and a plurality of wafer rests in the wafer holding disk having a wafer holding surface which is conically curved. When the wafer holding disk is rotated, the wafer is pushed onto the wafer holding surface so that the surface of the wafer is curved nearly in the same manner as the conically-curved inner surface of the peripheral portion of the s wafer holding disk As a result, an ion beam being irradiated upon the surface of the wafer is always perpendicular to the surface of the wafer.

    摘要翻译： 用于将离子注入一批半导体晶片的离子注入机包括离心保持型晶片保持盘，并且晶片保持盘中的多个晶片托架具有圆锥形弯曲的晶片保持表面。 当晶片保持盘旋转时，晶片被推到晶片保持表面上，使得晶片的表面几乎以与晶片保持盘的周边部分的锥形内表面相同的方式弯曲为 结果，照射在晶片表面上的离子束总是垂直于晶片的表面。

    Ameliorant for blood lipid metabolism
    6.
    发明授权
    Ameliorant for blood lipid metabolism 失效
    改善血脂代谢

    公开(公告)号：US5527801A

    公开(公告)日：1996-06-18

    申请号：US204430

    申请日：1994-03-14

    申请人： Yoshinobu Masuda ,  Hisao Minato ,  Akihisa Ikeno ,  Kunihiko Takeyama ,  Kanoo Hosoki

    发明人： Yoshinobu Masuda ,  Hisao Minato ,  Akihisa Ikeno ,  Kunihiko Takeyama ,  Kanoo Hosoki

    IPC分类号： A61K31/495 ,  C07D337/12

    CPC分类号： A61K31/495 ,  C07D337/12

    摘要： The present invention is to provide an ameliorant for blood lipid metabolism which comprises as an active ingredient N-(6,11-dihydrodibenzo[b,e]thiepin-11-yl)-4-(4-fluorophenyl)-1-piperazinebutanamide or a pharmaceutically acceptable salt thereof, more particularly, to provide a hyperlipidemia inhibitor and an atherosclerosis inhibitor.

    摘要翻译： PCT No.PCT / JP92 / 01173 Sec。 371日期：1994年3月14日 102（e）1994年3月14日PCT提交1992年9月14日PCT公布。 公开号WO93 / 05778 日期：1993年04月1日本发明提供一种血脂代谢改善剂，其包含作为活性成分的N-（6,11-二氢二苯并[b，e]硫杂-11-基）-4-（4- 氟苯基）-1-哌嗪丁酰胺或其药学上可接受的盐，更具体地，提供高脂血症抑制剂和动脉粥样硬化抑制剂。

    Apparatus for ion implantation including contactless cooling and beam current measurement means
    7.
    发明授权
    Apparatus for ion implantation including contactless cooling and beam current measurement means 失效
    用于离子注入的装置，包括非接触式冷却和束电流测量装置

    公开(公告)号：US5338940A

    公开(公告)日：1994-08-16

    申请号：US917208

    申请日：1992-07-21

    申请人： Kunihiko Takeyama

    发明人： Kunihiko Takeyama

    IPC分类号： H01J37/317 ,  H01J37/30 ,  G21K5/08

    CPC分类号： H01J37/3171 ,  H01J2237/2001 ,  H01J2237/20257 ,  H01J2237/31703

    摘要： Wafer disk holds wafers in position by centrifugal force and its rotating shaft is supported by a bearing capable of magnetic levitation that has a thrust bearing and radial bearings. An annular groove providing a heat radiating zone is formed under the wafer receiving faces of the wafer disk. A cooling plate cooled to a temperature not exceeding the temperature of liquid nitrogen is inserted into the groove in a contactless manner so that the wafer disk is cooled by heat radiation. In the absence of any area of physical contact in the mechanisms for axially supporting and cooling the wafer disk, ions can be implanted in low dose into wafers on the fast rotating disk while improving the quality of wafers after implantation. Further, no triboelectricity will develop, thereby contributing to an improvement in the precision of ion beam current measurement.

    摘要翻译： 晶圆盘通过离心力将晶片保持在适当位置，其旋转轴由具有推力轴承和径向轴承的磁悬浮轴承支撑。 在晶片盘的晶片接收面的下方形成设置散热区的环状槽。 将冷却至不超过液氮温度的冷却板以非接触的方式插入槽中，从而通过热辐射冷却晶片盘。 在用于轴向支撑和冷却晶片盘的机构中没有任何物理接触区域的情况下，可以将离子以低剂量注入快速旋转盘上的晶片中，同时改善植入后晶片的质量。 此外，不会产生摩擦电，从而有助于提高离子束电流测量的精度。

    Lymphoma associated molecules and uses therefor
    9.
    发明申请
    Lymphoma associated molecules and uses therefor 有权
    淋巴瘤相关分子及其用途

    公开(公告)号：US20070259342A1

    公开(公告)日：2007-11-08

    申请号：US11125015

    申请日：2005-05-09

    申请人： Margaret Shipp ,  Ricardo Aguiar ,  Liqun Gu ,  Kunihiko Takeyama

    发明人： Margaret Shipp ,  Ricardo Aguiar ,  Liqun Gu ,  Kunihiko Takeyama

    IPC分类号： C12Q1/68 ,  C07H21/04 ,  C07K14/00 ,  C07K16/18 ,  G01N33/53 ,  C12N15/00 ,  C12N5/06 ,  C12P1/04

    CPC分类号： C07K14/47 ,  A01K2217/05 ,  C07K2319/00

    摘要： The invention provides isolated nucleic acids molecules, designated BBAP nucleic acid molecules, which encode proteins that interact with or bind to BAL molecules, which are differentially expressed in non-Hodgkin's lymphoma. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing BBAP nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a BBAP gene has been introduced or disrupted. The invention still further provides isolated BBAP proteins, fusion proteins, antigenic peptides and anti-BBAP antibodies. Diagnostic methods using compositions of the invention are also provided.

    摘要翻译： 本发明提供分离的核酸分子，称为BBAP核酸分子，其编码与非霍奇金淋巴瘤差异表达的BAL分子相互作用或结合的蛋白质。 本发明还提供反义核酸分子，含有BBAP核酸分子的重组表达载体，其中引入了表达载体的宿主细胞，以及引入或破坏了BBAP基因的非人转基因动物。 本发明还进一步提供了分离的BBAP蛋白，融合蛋白，抗原肽和抗BBAP抗体。 还提供了使用本发明组合物的诊断方法。

    Tripeptide derivatives
    10.
    发明授权
    Tripeptide derivatives 失效

    公开(公告)号：US4826814A

    公开(公告)日：1989-05-02

    申请号：US046189

    申请日：1987-05-05

    申请人： Tadahiro Sawayama ,  Masatoshi Tsukamoto ,  Takashi Sasagawa ,  Kazuya Nishimura ,  Kanoo Hosoki ,  Kunihiko Takeyama

    发明人： Tadahiro Sawayama ,  Masatoshi Tsukamoto ,  Takashi Sasagawa ,  Kazuya Nishimura ,  Kanoo Hosoki ,  Kunihiko Takeyama

    IPC分类号： A61K38/00 ,  A61K38/05 ,  A61K38/06 ,  A61K38/55 ,  A61P9/00 ,  A61P9/12 ,  A61P43/00 ,  C07K1/02 ,  C07K1/113 ,  C07K5/02 ,  C07K5/06 ,  C07K5/068 ,  C07K5/08 ,  C07K14/81 ,  A61K37/43

    CPC分类号： C07K5/06086 ,  C07K5/0215 ,  A61K38/00

    摘要： There are provided tripeptide compounds represented by the following formula ##STR1## wherein R.sub.1 represents a C.sub.1-10 alkyl group, a C.sub.4-7 cycloalkyl or C.sub.5-7 cycloalkyl-lower alkyl group, a phenyl or phenyl-lower alkyl group in which the benzene ring may optionally be substituted by a substituent selected from halogen, lower alkyl, lower alkoxy, phenyl, methylenedioxy, ethylenedioxy, amino, di(lower alkyl)amino and hydroxy, a naphthyl or naphthyl-lower alkyl group in which the naphthalene ring may optionally be substituted by a substituent selected from halogen, lower alkyl, lower alkoxy and hydroxy, a heterocyclic or heterocyclic-lower alkyl group in which the heterocycle is a saturated or unsaturated 5- or 6-membered ring containing a nitrogen, oxygen or sulfur atom as the hetero atom, and may optionally be substituted by a substituent selected from halogen, lower alkyl, lower alkoxy, amino, di(lower alkyl)amino, hydroxy, oxo and saturated 5- or 6-membered nitrogen-containing heterocyclic group, and further may optionally be fused to a benzene ring, or an imidazolylvinyl group; R.sub.2 represents a hydrogen atom, a C.sub.1-10 alkyl group or a benzyl group; R.sub.3 represents a group of the formula ##STR2## represents a benzene, cyclopentane or cyclohexane ring, R.sub.4 represents a hydrogen atom, a C.sub.1-10 alkyl group or a benzyl group, p is 0 or 1, q is 1, 2, or 3, and X represents a phenyl group which may optionally be substituted by a substituent selected from halogen, lower alkoxy and hydroxy, a C.sub.4-8 cycloalkyl group, or a C.sub.5-7 cycloalkyl group which is fused to a benzene, and Y represents a hydrogen atom or a lower alkyl group, or X and Y, together with the nitrogen and carbon atoms to which they are bonded, forms a 5- or 6-membered heterocycle which may contain a nitrogen, oxygen or sulfur atom,W represents a single bond, --O-- or --NH--, T represents a single bond, ##STR3## and m is 2 or 3, or salts thereof and processes for production thereof. The compounds are useful as antihypertensive agents.